199 related articles for article (PubMed ID: 16784793)
1. Studies on a new carrier of trimethylsilyl-modified mesoporous material for controlled drug delivery.
Tang Q; Xu Y; Wu D; Sun Y; Wang J; Xu J; Deng F
J Control Release; 2006 Aug; 114(1):41-6. PubMed ID: 16784793
[TBL] [Abstract][Full Text] [Related]
2. Mesoporous silica material TUD-1 as a drug delivery system.
Heikkilä T; Salonen J; Tuura J; Hamdy MS; Mul G; Kumar N; Salmi T; Murzin DY; Laitinen L; Kaukonen AM; Hirvonen J; Lehto VP
Int J Pharm; 2007 Feb; 331(1):133-8. PubMed ID: 17046183
[TBL] [Abstract][Full Text] [Related]
3. Organically modified MCM-type material preparation and its usage in controlled amoxicillin delivery.
Li Z; Su K; Cheng B; Deng Y
J Colloid Interface Sci; 2010 Feb; 342(2):607-13. PubMed ID: 19948346
[TBL] [Abstract][Full Text] [Related]
4. Inclusion of ibuprofen in mesoporous templated silica: drug loading and release property.
Charnay C; Bégu S; Tourné-Péteilh C; Nicole L; Lerner DA; Devoisselle JM
Eur J Pharm Biopharm; 2004 May; 57(3):533-40. PubMed ID: 15093603
[TBL] [Abstract][Full Text] [Related]
5. Hybrid organic-inorganic silica gel carriers with controlled drug-delivery properties.
Contessotto L; Ghedini E; Pinna F; Signoretto M; Cerrato G; Crocellà V
Chemistry; 2009 Nov; 15(44):12043-9. PubMed ID: 19774561
[TBL] [Abstract][Full Text] [Related]
6. Influence of surface chemistry of mesoporous alumina with wide pore distribution on controlled drug release.
Kapoor S; Hegde R; Bhattacharyya AJ
J Control Release; 2009 Nov; 140(1):34-9. PubMed ID: 19654029
[TBL] [Abstract][Full Text] [Related]
7. Submicron particles of SBA-15 modified with MgO as carriers for controlled drug delivery.
Shen S; Chow PS; Chen F; Tan RB
Chem Pharm Bull (Tokyo); 2007 Jul; 55(7):985-91. PubMed ID: 17603186
[TBL] [Abstract][Full Text] [Related]
8. Preparation and characterization of glycidyl methacrylate organo bridges grafted mesoporous silica SBA-15 as ibuprofen and mesalamine carrier for controlled release.
Rehman F; Rahim A; Airoldi C; Volpe PLO
Mater Sci Eng C Mater Biol Appl; 2016 Feb; 59():970-979. PubMed ID: 26652455
[TBL] [Abstract][Full Text] [Related]
9. Effective controlled release of captopril by silylation of mesoporous MCM-41.
Qu F; Zhu G; Huang S; Li S; Qiu S
Chemphyschem; 2006 Feb; 7(2):400-6. PubMed ID: 16411260
[TBL] [Abstract][Full Text] [Related]
10. Fluorescent mesoporous silica nanotubes incorporating CdS quantum dots for controlled release of ibuprofen.
Yang YJ; Tao X; Hou Q; Chen JF
Acta Biomater; 2009 Nov; 5(9):3488-96. PubMed ID: 19442764
[TBL] [Abstract][Full Text] [Related]
11. Luminescence functionalization of SBA-15 by YVO4:Eu3+ as a novel drug delivery system.
Yang P; Huang S; Kong D; Lin J; Fu H
Inorg Chem; 2007 Apr; 46(8):3203-11. PubMed ID: 17371013
[TBL] [Abstract][Full Text] [Related]
12. Functionalized SBA-15 materials as carriers for controlled drug delivery: influence of surface properties on matrix-drug interactions.
Song SW; Hidajat K; Kawi S
Langmuir; 2005 Oct; 21(21):9568-75. PubMed ID: 16207037
[TBL] [Abstract][Full Text] [Related]
13. Ordered mesoporous silica modified with lanthanum for ibuprofen loading and release behaviour.
Goscianska J; Olejnik A; Nowak I; Marciniak M; Pietrzak R
Eur J Pharm Biopharm; 2015 Aug; 94():550-8. PubMed ID: 26170160
[TBL] [Abstract][Full Text] [Related]
14. A magnetic, luminescent and mesoporous core-shell structured composite material as drug carrier.
Yang P; Quan Z; Hou Z; Li C; Kang X; Cheng Z; Lin J
Biomaterials; 2009 Sep; 30(27):4786-95. PubMed ID: 19520428
[TBL] [Abstract][Full Text] [Related]
15. Cortisol controlled release by mesoporous silica.
Lopez T; Ortiz E; Alexander-Katz R; Basaldella E; Bokhimi X
Nanomedicine; 2009 Jun; 5(2):170-7. PubMed ID: 19091634
[TBL] [Abstract][Full Text] [Related]
16. "Graft to" Synthesis and Ibuprofen-Loading Performance of pH-Sensitive PMAA-Silica Hybrid Nanoparticles with Controlled Bimodal Mesopores.
Han J; Sun J; Bai S; Panezai H; Jin X; Wu X
J Pharm Sci; 2015 Dec; 104(12):4299-4306. PubMed ID: 26501935
[TBL] [Abstract][Full Text] [Related]
17. Potential of amorphous microporous silica for ibuprofen controlled release.
Aerts CA; Verraedt E; Depla A; Follens L; Froyen L; Van Humbeeck J; Augustijns P; Van den Mooter G; Mellaerts R; Martens JA
Int J Pharm; 2010 Sep; 397(1-2):84-91. PubMed ID: 20619331
[TBL] [Abstract][Full Text] [Related]
18. Sol-gel synthesis of a multifunctional, hierarchically porous silica/apatite composite.
Andersson J; Areva S; Spliethoff B; Lindén M
Biomaterials; 2005 Dec; 26(34):6827-35. PubMed ID: 15993485
[TBL] [Abstract][Full Text] [Related]
19. Luminescence functionalization of mesoporous silica with different morphologies and applications as drug delivery systems.
Yang P; Quan Z; Lu L; Huang S; Lin J
Biomaterials; 2008 Feb; 29(6):692-702. PubMed ID: 17996294
[TBL] [Abstract][Full Text] [Related]
20. Flexible porous metal-organic frameworks for a controlled drug delivery.
Horcajada P; Serre C; Maurin G; Ramsahye NA; Balas F; Vallet-Regí M; Sebban M; Taulelle F; Férey G
J Am Chem Soc; 2008 May; 130(21):6774-80. PubMed ID: 18454528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
